We studied the anti-growth and apoptotic effects of paclitaxel and epidermal growth factor receptor (EGFR) antisense gene therapy in a head and neck squamous cell carcinoma model (SCC 1483). An
in vitro study showed paclitaxel at a low concentration of 5 nM for 24 hours effectively blocks cell proliferation. Downmodulation of EGFR in head and neck cancer cell by antisense EGFR effectively inhibits cell proliferation compared to sense EGFR. The combination of paclitaxel and antisense EGFR gene therapy
in vitro showed a synergistic effect and suppressed tumor growth most effectively. Tumor cells treated with antisense EGFR showed a higher percentage of apoptopic cells compared to cells treated with sense EGFR. Compared to individual effects, the combination of paclitaxel and antisense EGFR gene therapy suppressed tumor growth more effectively. Our results indicate antisense EGFR gene therapy and paclitaxel are useful for clinical chemotherapy in head and neck squamous cell carcinoma.
View full abstract